Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.952 | 21 | 0 | 2011 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 20 | 3 | 2007 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.100 | None | 1.000 | 19 | 1 | 2002 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 18 | 2 | 2000 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 1.000 | 18 | 0 | 1996 | 2019 | ||||||||
|
G protein-coupled estrogen receptor 1 | 0.505 | 0.731 | 0.57 |
|
disease | 0.100 | None | 0.882 | 17 | 0 | 2006 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 1999 | 2018 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2006 | 2019 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2004 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 1992 | 2018 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1999 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2002 | 2020 | |||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 15 | 1 | 1990 | 2018 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 0.867 | 15 | 0 | 1994 | 2019 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2002 | 2020 | |||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 0.929 | 14 | 1 | 2001 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.100 | None | 0.846 | 13 | 5 | 2003 | 2016 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.400 | None | 0.846 | 13 | 5 | 1994 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 2 | 2004 | 2016 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.100 | None | 0.667 | 12 | 3 | 1997 | 2013 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.200 | None | 1.000 | 12 | 1 | 1999 | 2018 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2007 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.100 | None | 1.000 | 11 | 2 | 2005 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1999 | 2018 | |||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 2011 | 2020 |